Arcellx (ACLX) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChart

ACLX Stock Forecast


Arcellx stock forecast is as follows: an average price target of $83.00 (represents a -5.50% downside from ACLX’s last price of $87.83) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.

ACLX Price Target


The average price target for Arcellx (ACLX) is $83.00 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $122.00 to $32.00. This represents a potential -5.50% downside from ACLX's last price of $87.83.

ACLX Analyst Ratings


Buy

According to 11 Wall Street analysts, Arcellx's rating consensus is 'Buy'. The analyst rating breakdown for ACLX stock is 0 'Strong Buy' (0.00%), 11 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Arcellx Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 08, 2024Biren AminPiper Sandler$115.00$101.0913.76%30.93%
Nov 06, 2024Jack AllenRobert W. Baird$106.00$86.0823.13%20.69%
Nov 06, 2024Emily BodnarH.C. Wainwright$95.00$86.0810.36%8.16%
Oct 29, 2024Cory KasimovEvercore ISI$120.00$84.9941.19%36.63%
Oct 18, 2024Ben BurnettStifel Nicolaus$122.00$95.2728.06%38.90%
May 31, 2024Biren AminPiper Sandler$70.00$52.2434.00%-20.30%
May 15, 2024Benjamin BurnettStifel Nicolaus$83.00$50.6263.97%-5.50%
May 13, 2024Cory KasimovEvercore ISI$85.00$49.7770.79%-3.22%
Mar 18, 2024Gil BlumNeedham$81.00$69.1117.20%-7.78%
Dec 12, 2022-Needham$35.00$28.8421.34%-60.15%
Row per page
Go to

The latest Arcellx stock forecast, released on Nov 08, 2024 by Biren Amin from Piper Sandler, set a price target of $115.00, which represents a 13.76% increase from the stock price at the time of the forecast ($101.09), and a 30.93% increase from ACLX last price ($87.83).

Arcellx Price Target by Period


1M3M12M
# Anlaysts559
Avg Price Target$111.60$111.60$97.44
Last Closing Price$87.83$87.83$87.83
Upside/Downside27.06%27.06%10.94%

In the current month, the average price target of Arcellx stock is $111.60, according to 5 Wall Street analysts offering twelve months forecast. The average price target represents a 27.06% increase as opposed to Arcellx's last price of $87.83. This month's average price target is down 0.00% compared to last quarter, and up 14.53% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Nov 08, 2024Piper SandlerOverweightOverweightHold
Nov 06, 2024CitigroupBuyBuyHold
Nov 06, 2024H.C. WainwrightBuyBuyHold
Nov 05, 2024Bank of America SecuritiesBuyBuyHold
Oct 29, 2024Evercore ISIOutperformOutperformHold
Oct 18, 2024NeedhamBuyBuyHold
Sep 03, 2024Cantor Fitzgerald-OverweightInitialise
Jul 22, 2024Piper SandlerBuyBuyHold
Jul 22, 2024NeedhamUnderperformUnderperformHold
Jun 18, 2024Piper SandlerBuyBuyHold
Row per page
Go to

Arcellx's last stock rating was published by Piper Sandler on Nov 08, 2024. The company gave ACLX a "Overweight" rating, the same as its previous rate.

Arcellx Financial Forecast


Arcellx Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
Revenue------------$63.15M$14.96M$14.30M$17.91M-
Avg Forecast$100.60M$85.80M$26.03M$26.03M$34.43M$22.31M$21.25M$21.25M$25.47M$38.73M$22.04M$20.67M$20.07M$17.49M$39.29M$100.97M$3.00M
High Forecast$137.82M$117.55M$35.66M$35.66M$47.17M$30.57M$29.12M$23.19M$34.39M$38.87M$22.04M$20.67M$25.12M$17.92M$53.83M$138.33M$4.11M
Low Forecast$71.37M$60.87M$18.47M$18.47M$24.43M$15.83M$15.08M$19.32M$15.99M$38.59M$22.04M$20.67M$15.07M$17.07M$27.88M$71.64M$2.13M
# Analysts22221114943475632
Surprise %------------3.15%0.86%0.36%0.18%-

Arcellx's average Quarter revenue forecast for Mar 24 based on 4 analysts is $20.67M, with a low forecast of $20.67M, and a high forecast of $20.67M. ACLX's average Quarter revenue forecast represents a -67.27% decrease compared to the company's last Quarter revenue of $63.15M (Dec 23).

Arcellx EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
# Analysts22221114943475632
EBITDA------------$35.76M$-44.86M$-29.56M$-25.56M$-35.29M
Avg Forecast$68.78M$58.66M$17.80M$17.80M$23.54M$15.26M$14.53M$14.53M$17.42M$26.48M$15.07M$14.13M$13.72M$11.96M$26.86M$69.04M$2.05M
High Forecast$94.23M$80.37M$24.38M$24.38M$32.25M$20.90M$19.91M$15.85M$23.51M$26.57M$15.07M$14.13M$17.18M$12.25M$36.80M$94.58M$2.81M
Low Forecast$48.80M$41.62M$12.63M$12.63M$16.70M$10.82M$10.31M$13.21M$10.94M$26.38M$15.07M$14.13M$10.31M$11.67M$19.06M$48.98M$1.46M
Surprise %------------2.61%-3.75%-1.10%-0.37%-17.20%

4 analysts predict ACLX's average Quarter EBITDA for Mar 24 to be $14.13M, with a high of $14.13M and a low of $14.13M. This is -60.49% lower than Arcellx's previous annual EBITDA (Dec 23) of $35.76M.

Arcellx Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
# Analysts22221114943475632
Net Income------------$19.52M$-39.34M$-23.85M$-27.34M$-37.41M
Avg Forecast$-38.79M$-43.67M$-53.82M$-50.36M$-31.35M$-39.06M$-38.08M$-34.78M$-30.14M$-16.67M$-27.93M$-27.33M$-28.66M$-29.58M$-39.55M$98.06M$-52.50M
High Forecast$-24.14M$-27.18M$-33.49M$-31.34M$-19.51M$-24.31M$-23.70M$-25.30M$-590.95K$-10.37M$-17.38M$-17.01M$-14.56M$-18.41M$-24.61M$145.23M$-32.67M
Low Forecast$-57.45M$-64.68M$-79.70M$-74.58M$-46.43M$-57.85M$-56.40M$-41.11M$-52.00M$-24.68M$-41.36M$-40.48M$-50.05M$-43.80M$-58.57M$61.03M$-77.76M
Surprise %-------------0.68%1.33%0.60%-0.28%0.71%

Arcellx's average Quarter net income forecast for Mar 24 is $-27.33M, with a range of $-40.48M to $-17.01M. ACLX's average Quarter net income forecast represents a -240.04% decrease compared to the company's last Quarter net income of $19.52M (Dec 23).

Arcellx SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
# Analysts22221114943475632
SG&A------------$19.37M$16.01M$15.54M$15.44M$14.06M
Avg Forecast$92.58M$78.96M$23.96M$23.96M$31.68M$20.54M$19.56M$19.56M$23.44M$35.64M$20.28M$19.02M$18.47M$16.10M$36.16M$92.92M$2.76M
High Forecast$126.84M$108.18M$32.82M$32.82M$43.41M$28.13M$26.80M$21.34M$31.65M$35.77M$20.28M$19.02M$23.12M$16.49M$49.54M$127.31M$3.78M
Low Forecast$65.68M$56.02M$17.00M$17.00M$22.48M$14.57M$13.88M$17.78M$14.72M$35.51M$20.28M$19.02M$13.87M$15.71M$25.65M$65.93M$1.96M
Surprise %------------1.05%0.99%0.43%0.17%5.09%

Arcellx's average Quarter SG&A projection for Mar 24 is $19.02M, based on 4 Wall Street analysts, with a range of $19.02M to $19.02M. The forecast indicates a -1.80% fall compared to ACLX last annual SG&A of $19.37M (Dec 23).

Arcellx EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
# Analysts22221114943475632
EPS-------------$-0.00$-0.00$-0.58$-1.03
Avg Forecast$-0.72$-0.81$-1.00$-0.94$-0.58$-0.73$-0.71$-0.65$-0.56$-0.31$-0.52$-0.51$-0.53$-0.55$-0.73$1.82$-0.98
High Forecast$-0.45$-0.50$-0.62$-0.58$-0.36$-0.45$-0.44$-0.47$-0.01$-0.19$-0.32$-0.32$-0.27$-0.34$-0.46$2.70$-0.61
Low Forecast$-1.07$-1.20$-1.48$-1.39$-0.86$-1.07$-1.05$-0.76$-0.97$-0.46$-0.77$-0.75$-0.93$-0.81$-1.09$1.13$-1.44
Surprise %-------------0.00%0.00%0.00%-0.32%1.06%

According to 4 Wall Street analysts, Arcellx's projected average Quarter EPS for Mar 24 is $-0.51, with a low estimate of $-0.75 and a high estimate of $-0.32. This represents a -127045.00% decrease compared to ACLX previous annual EPS of - (Dec 23).

Arcellx Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
VTYXVentyx Biosciences$1.87$33.861710.70%Buy
BMEABiomea Fusion$6.53$22.75248.39%Buy
DAWNDay One Biopharmaceuticals$13.31$38.80191.51%Buy
NUVLNuvalent$86.88$111.5728.42%Buy
AMLXAmylyx Pharmaceuticals$4.76$5.3311.97%Buy
ACLXArcellx$87.83$83.00-5.50%Buy

ACLX Forecast FAQ


Is Arcellx a good buy?

Yes, according to 11 Wall Street analysts, Arcellx (ACLX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 11 'Buy' recommendations, accounting for 100.00% of ACLX's total ratings.

What is ACLX's price target?

Arcellx (ACLX) average price target is $83 with a range of $32 to $122, implying a -5.50% from its last price of $87.83. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Arcellx stock go up soon?

According to Wall Street analysts' prediction for ACLX stock, the company can go down by -5.50% (from the last price of $87.83 to the average price target of $83), up by 38.90% based on the highest stock price target, and down by -63.57% based on the lowest stock price target.

Can Arcellx stock reach $130?

ACLX's average twelve months analyst stock price target of $83 does not support the claim that Arcellx can reach $130 in the near future.

What is Arcellx's current price target trend?

5 Wall Street analysts forecast a $111.6 price target for Arcellx (ACLX) this month, up 27.06% from its last price of $87.83. Compared to the last 3 and 12 months, the average price target increased by 27.06% and increased by 10.94%, respectively.

What are Arcellx's analysts' financial forecasts?

Arcellx's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $99.25M (high $130.04M, low $74.66M), average EBITDA is $67.86M (high $88.91M, low $51.05M), average net income is $-143M (high $-92.813M, low $-202M), average SG&A $91.34M (high $119.68M, low $68.71M), and average EPS is $-2.662 (high $-1.724, low $-3.749). ACLX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $238.46M (high $326.69M, low $169.18M), average EBITDA is $163.04M (high $223.36M, low $115.67M), average net income is $-187M (high $-116M, low $-276M), average SG&A $219.45M (high $300.65M, low $155.7M), and average EPS is $-3.468 (high $-2.158, low $-5.136).

Did the ACLX's actual financial results beat the analysts' financial forecasts?

Based on Arcellx's last annual report (Dec 2023), the company's revenue was $110.32M, which missed the average analysts forecast of $177.82M by -37.96%. Apple's EBITDA was $-89.88M, missing the average prediction of $121.58M by -173.93%. The company's net income was $-70.69M, missing the average estimation of $276.64K by -25652.60%. Apple's SG&A was $66.35M, missing the average forecast of $163.65M by -59.46%. Lastly, the company's EPS was $-0.0015, missing the average prediction of $0.00514 by -129.18%. In terms of the last quarterly report (Dec 2023), Arcellx's revenue was $63.15M, beating the average analysts' forecast of $20.07M by 214.71%. The company's EBITDA was $35.76M, beating the average prediction of $13.72M by 160.67%. Arcellx's net income was $19.52M, missing the average estimation of $-28.663M by -168.08%. The company's SG&A was $19.37M, beating the average forecast of $18.47M by 4.87%. Lastly, the company's EPS was $0.0004, missing the average prediction of $-0.533 by -100.08%